LLMs are shaping the future, but they’re still missing something.
Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback